Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Current Liabilities (2016 - 2026)

Conmed filings provide 17 years of Total Current Liabilities readings, the most recent being $292.7 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 3.38% to $292.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $292.7 million, a 3.38% increase, with the full-year FY2025 number at $315.0 million, up 13.27% from a year prior.
  • Total Current Liabilities hit $292.7 million in Q1 2026 for Conmed, down from $315.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $376.3 million in Q3 2023 to a low of $187.6 million in Q1 2022.
  • Median Total Current Liabilities over the past 5 years was $292.7 million (2026), compared with a mean of $286.7 million.
  • Biggest five-year swings in Total Current Liabilities: surged 80.42% in 2023 and later fell 24.98% in 2024.
  • Conmed's Total Current Liabilities stood at $296.6 million in 2022, then rose by 4.78% to $310.7 million in 2023, then dropped by 10.49% to $278.1 million in 2024, then grew by 13.27% to $315.0 million in 2025, then dropped by 7.09% to $292.7 million in 2026.
  • The last three reported values for Total Current Liabilities were $292.7 million (Q1 2026), $315.0 million (Q4 2025), and $314.7 million (Q3 2025) per Business Quant data.